Side-by-side comparison of AI visibility scores, market position, and capabilities
SF YC W21 AI workflow automation for customer support teams on Zendesk; $3.33M Greycroft/YC-backed improving agent handle time and first-contact resolution with no-code workflow builder competing with Forethought AI for enterprise support operations automation.
FlowEQ is a San Francisco-based AI workflow automation platform for customer support teams — backed by Y Combinator (W21) with $3.33 million in total funding from Greycroft and Y Combinator — providing enterprise customer service organizations using Zendesk and other helpdesk systems with intelligent process guidance, no-code workflow automation, and AI-driven decision support that improves agent efficiency and reduces handle time across technology, e-commerce, and financial services sectors. Founded in 2020, FlowEQ helps support teams standardize responses, reduce first-contact resolution failures, and automate routine decision workflows that would otherwise require agents to manually navigate multiple knowledge sources and policy documents.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.